Market Research Logo

Global Kaposi Sarcoma Market 2017-2021

Global Kaposi Sarcoma Market 2017-2021

About Kaposi Sarcoma

Kaposi sarcoma is a multicentral tumor. The tumor is caused by Kaposi sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV8). It can occur as endemic, classic, epidemic, and iatrogenic forms. Epidemic or acquired immune deficiency syndrome (AIDS)-associated form of treatment is one of the most prevalent types followed in the treatment of Kaposi sarcoma globally. The diagnosis is done by biopsy, and major treatment types include chemotherapy, HAART, and immunotherapy. HAART is the most common type of treatment due to a high prevalence rate of AIDS-associated Kaposi sarcoma.

Technavio’s analysts forecast the global Kaposi sarcoma market to grow at a CAGR of 2.46% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global Kaposi sarcoma market for 2017-2021. To calculate the market size, the report considers the sales of both generic as well as branded drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Kaposi Sarcoma Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
Other prominent vendors
  • Eli Lilly
  • Pfizer
Market driver
  • Rising number of organ transplants
  • For a full, detailed list, view our report
Market challenge
  • High cost of treatment
  • For a full, detailed list, view our report
Market trend
  • Increasing consolidation in the cancer treatment market
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Kaposi Sarcoma Market 2017-2021

Technavio recognizes the following companies as the key players in the global Kaposi sarcoma market: Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, and Merck.

Other Prominent Vendors in the market are: Eli Lilly and Pfizer.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is increasing consolidation in the cancer treatment market. Past several years have witnessed significant consolidation in the cancer treatment industry. There can be seen a trend of movement of cancer treatment from clinics to hospitals. Studies have shown that there is a rise in a number of oncology clinics that got acquired by hospitals.”

According to the report, one of the major drivers for this market is rising number of organ transplants. Organ transplant is the transfer of organs from donor to recipient. It is done with the aim of restoring the functions of the body. In many occasions, organ transplantation is the only treatment option left at the end stage of organ failures such as heart or liver failure. The organ transplant process has rapidly increased during the last few years. The rising improvement rate in the post-transplant outcome and increasing success rate has led to high adoption for the organ transplant.

Further, the report states that one of the major factors hindering the growth of this market is high cost of treatment. The high cost of treatment is a major problem for the cancer patients. The majority of the cancer treatments available for the individuals are out of their budget and ultimately forces the individual or the payer to skip the treatment. This can be understood from the fact that an average US family earns around $50,000-52,000 annually. The cancer treatment can cost up to $125,000 per annum. An insured person has an out-of-pocket expense of around $20,000-$30,000; it is clearly more than half of the family’s income. This is a huge problem faced by population across the world, and as a result, a large number of individuals either compromise or skip the prescribed treatment.

Companies Mentioned

Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Eli Lilly and Pfizer.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Key market highlights
  • An overview of Kaposi sarcoma
    • Table Types of Kaposi sarcoma
    • Table Treatment overview for Kaposi sarcoma
  • Market landscape
    • Market overview
      • Table Global Kaposi sarcoma market snapshot
    • Market size and forecast
      • Table Global Kaposi sarcoma market 2016-2021 ($ millions)
      • Table Opportunity analysis in global Kaposi sarcoma market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Key pipeline candidates by sponsors/collaborators
    • Table Pipeline analysis
  • Market segmentation by type of treatment
    • Table Segmentation of global Kaposi sarcoma market by type of treatment
    • HAART
      • Table Combination antiretroviral therapy (ART): Common inclusions
      • Table Global Kaposi sarcoma HAART therapy market 2016-2021 ($ millions)
      • Table Change in HIV/AIDS population 2010-2015
    • Chemotherapy
      • Table Major types of chemotherapy
      • Table Global Kaposi sarcoma chemotherapy market 2016-2021 ($ millions)
      • Table Advantages and disadvantages of chemotherapy
    • Immunotherapy
      • Table Global Kaposi sarcoma immunotherapy market 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Segmentation of global Kaposi sarcoma market based on geography 2016 and 2021
    • Table Kaposi sarcoma market revenue by geography 2016-2021 ($ millions)
    • Kaposi sarcoma market in Americas
      • Table Market scenario in Americas
      • Table Kaposi sarcoma market in Americas 2016-2021 ($ millions)
    • Kaposi sarcoma market in EMEA
      • Table Market scenario in EMEA
      • Table Kaposi sarcoma market in EMEA 2016-2021 ($ millions)
    • Kaposi sarcoma market in APAC
      • Table Market scenario in APAC
      • Table Kaposi sarcoma market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Percentage distribution of organ transplants in US 1988-2016
      • Table Total global population living with HIV/AIDS (million)
      • Table Global number of people living with and died due to AIDS/HIV 2014-2015 (million)
      • Table Kaposi sarcoma: Before and after the AIDS epidemic in US
    • Market challenges
  • Market trends
    • Increasing consolidation in the cancer treatment market
    • Emphasis on combination therapy
    • Application of Kaposi sarcoma-specific treatment (local treatment)
  • Vendor landscape
    • Competitive scenario
      • Table Competitive analysis of global Kaposi sarcoma market
  • Key vendor analysis
    • Bristol-Myers Squibb
      • Table Bristol-Myers Squibb: Key highlights
      • Table Bristol-Myers Squibb: Strength assessment
      • Table Bristol-Myers Squibb: Strategy assessment
      • Table Bristol-Myers Squibb: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Key highlights
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Johnson & Johnson
      • Table Johnson & Johnson: Key highlights
      • Table Johnson & Johnson: Strength assessment
      • Table Johnson & Johnson: Strategy assessment
      • Table Johnson & Johnson: Opportunity assessment
    • Merck
      • Table Merck: Key highlights
      • Table Merck: Strength assessment
      • Table Merck Strategy assessment
      • Table Merck: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report